RAN-Zopiclone (2015-09-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 487796 | RAN-Zopiclone | - Recalling Firm
- Ranbaxy Pharmaceuticals Canada Inc.
- 200-2680 Matheson Blvd. East
- Mississauga
- L4W 0A5
- Ontario
- CANADA
- Marketing Authorization Holder
- Ranbaxy Pharmaceuticals Canada Inc.
- 200-2680 Matheson Blvd. East
- Mississauga
- L4W 0A5
- Ontario
- CANADA
| Tablet | DIN 02267926 | Zopiclone 7.5 mg |
Affected Products
RAN-Zopiclone
Lot may contain oversized tablets exceeding the maximum recommended daily dose of 7.5 mg